Web31. mar 2024 · Peter Thiel, in full Peter Andreas Thiel, (born October 11, 1967, Frankfurt am Main, West Germany), German American entrepreneur and business executive who helped … Web15. dec 2024 · Another emerging trend in Thiel’s portfolio is psychedelics. In November, he invested in ATAI Life Sciences, a German biotech firm which is developing a range of drugs for mental health treatment, including ketamine, MDMA and psilocybin — the psychoactive ingredient in magic mushrooms.
Peter Thiel-backed Atai snaps up Compass Pathways shares - CNBC
WebA British start-up using the active ingredient in so-called magic mushrooms to treat clinical depression has raised $80 million from investors, including Peter Thiel, the billionaire … WebPred 1 dňom · Name: Peter Andreas Thiel. Geboren: 11. Oktober 1967 in Frankfurt am Main (Deutschland) Ausbildung: Philosophie (BA) an der Stanford University, … how many open positions in the us
A Blooming Opportunity For Investors To Cash In On Mushroom …
Web11. dec 2024 · A for-profit company that Peter Thiel invests in has plans to start clinical trials of magic mushrooms for depression within the first three months of 2024. Web3. mar 2024 · Thiel, a billionaire venture capitalist who famously-and lucratively-made a ground-floor investment in Facebook's early days, saw his firm Palantir go public last year. The firm is now worth... Web29. nov 2024 · Atai Life Sciences, the Peter Thiel-backed start-up that wants to use psychedelic drugs to treat mental health conditions, has increased its stake in fellow drug developer Compass Pathways. Atai ... how big is geico insurance